Natalie McDonald
Vorstandsvorsitzender bei Create Group NYC LLC
Profil
Natalie McDonald is the founder and President & CEO of Create Group NYC LLC since 2009.
She is currently working as a Director at Elucida Oncology, Inc. since 2021.
Ms. McDonald has an undergraduate degree from the University of Pittsburgh and an MBA from Drexel University.
Aktive Positionen von Natalie McDonald
| Unternehmen | Position | Beginn |
|---|---|---|
Create Group NYC LLC
 Create Group NYC LLC Advertising/Marketing ServicesCommercial Services Create Group NYC LLC provides on-demand healthcare advertising services. It offers flat-free advertising, flat-free adaption, and short-term marketing services. The company was founded by Natalie McDonald in 2009 and is headquartered in New York, NY. | Vorstandsvorsitzender | 01.01.2009 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Direktor/Vorstandsmitglied | 29.04.2021 |
Ausbildung von Natalie McDonald
| University of Pittsburgh | Undergraduate Degree |
| Drexel University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Create Group NYC LLC
Create Group NYC LLC Advertising/Marketing ServicesCommercial Services Create Group NYC LLC provides on-demand healthcare advertising services. It offers flat-free advertising, flat-free adaption, and short-term marketing services. The company was founded by Natalie McDonald in 2009 and is headquartered in New York, NY. | Commercial Services |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Health Technology |
